OBJECTIVES: We sought to assess the ability of N-terminal pro-B-type natriuretic peptide (N-BNP) to predict vascular events in high-risk people and to test whether statins benefit people with high levels of N-BNP.
BACKGROUND: The predictive value of N-BNP for occlusive vascular events and the effects of statins in people with high N-BNP levels are uncertain.
METHODS: A total of 20,536 people were assigned randomly to simvasta...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher version
- Elsevier B.V. Publisher's website
- Journal of the American College of Cardiology Journal website
- Publication date:
- Source identifiers:
- Local pid:
- Copyright holder:
- Elsevier B.V.
- Copyright date:
- Copyright 2007 the American College of Cardiology Foundation. Published by Elsevier B.V. All rights reserved. Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://www.elsevier.com/open-access/userlicense/1.0/
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
If you are the owner of this record, you can report an update to it here: Report update to this record